Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245691

Medchemexpress LLC S-methyl-KE-298 | 143584-75-2 | MFCD31382145 | 98.0% | 252.33 g/mol | C13H16O3S | 10 MG
SDP

Catalog No. 5000245691
Encompass_Preferred

S-methyl-KE-298 is the active metabolite of KE-298 reported to inhibit matrix metalloproteinase-1 (MMP-1) production in rheumatoid arthritis synovial cells. Supplied as a solid research chemical, it is intended for in vitro studies and characterization and is provided with defined purity and storage conditions.

  • Active metabolite of KE-298.
  • Inhibits MMP-1 production in rheumatoid arthritis synovial cells.
  • High purity (98.0%).
  • Solid, white to off-white appearance.
  • Molecular formula C13H16O3S; molecular weight 252.33 g/mol.
  • Recommended storage conditions for powder and for solutions.

Catalog No. 50-002-45691 Supplier Medchemexpress LLC Supplier No. HY10167110MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

S-methyl-KE-298 is the active metabolite of KE-298 reported to inhibit matrix metalloproteinase-1 (MMP-1) production in rheumatoid arthritis synovial cells. Supplied as a solid research chemical, it is intended for in vitro studies and characterization and is provided with defined purity and storage conditions.

  • Active metabolite of KE-298.
  • Inhibits MMP-1 production in rheumatoid arthritis synovial cells.
  • High purity (98.0%).
  • Solid, white to off-white appearance.
  • Molecular formula C13H16O3S; molecular weight 252.33 g/mol.
  • Recommended storage conditions for powder and for solutions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.